新型冠状病毒肺炎疫情下国家药品抽检工作防控要点分析与建议  

Key Points Analysis and Suggestions for the Prevention and Control of Coronavirus Disease 2019 Epidemic During National Drug Sampling and Testing

作　　者：刘文[1] 王翀[1] 朱炯[1] LIU Wen;WANG Chong;ZHU Jiong(National Institute for Food and Drug Control,Bejing,China 102629)

机构地区：[1]中国食品药品检定研究院,北京102629

出　　处：《中国药业》2020年第8期1-3,共3页China Pharmaceuticals

摘　　要：目的为新型冠状病毒肺炎(简称新冠肺炎)疫情下做好国家药品抽检工提供参考。方法梳理国家药品抽检工作中的职业暴露环节,分析新冠肺炎疫情防控要点和继续做好防控工作所面临的形势,提出针对性建议。结果与结论目前,国家药品抽检工作中的新冠肺炎疫情防控状况良好,但疫情仍未解除。建议在下一步抽检工作中建议提高网络技术利用率,优化工作安排,全面落实防控措施,重视工作外的防控,继续做好新冠肺炎疫情防控。Objective To provide reference for the prevention and control of the coronavirus disease 2019(COVID-19)epidemic during national drug sampling and testing.Methods The occupational exposure in the national drug sampling and testing was combed,the key points of the COVID-19 epidemic prevention and control were analyzed,the situation faced by the future prevention and control work was analyzed and the targeted suggestions were put forward.Results and Conclusion At present,the prevention and control work of COVID-19 epidemic is satisfactory during the national drug sampling and testing,but the epidemic situation has not yet been resolved.It is suggested to improve the utilization rate of network technology,optimize the work arrangements for drug sampling and testing,implement the prevention and control measures comprehensively,pay attention to the prevention and control in spare time,and continue to do a good job in epidemic prevention and control.

关 键 词：新型冠状病毒肺炎 国家药品抽检 疫情防控 职业暴露 

分 类 号：R95[医药卫生—药学] R184